Germany is making the one-shot Johnson & Johnson coronavirus vaccine available to all adults as it did with the AstraZeneca vaccine, though the bulk of the expected deliveries is still some way off.
Germany has recommended the AstraZeneca shot mainly for over-60s because of a rare type of blood clot seen in an extremely small number of recipients. But amid a push to get as many people inoculated as possible, the government decided to allow doctors' offices to vaccinate any adults with it -- putting aside a priority system under which the oldest and most vulnerable have been vaccinated first.
Health Minister Jens Spahn said authorities decided Monday to take the same approach with the Johnson & Johnson vaccine, about which there are similar concerns. He estimated that 5 to 6 million over-60s in Germany still need to be vaccinated and that should be concluded by early June.
Spahn said the largest deliveries from Johnson & Johnson, more than 10 million doses, are expected in June or July.
Germany has now given nearly one-third of the population at least one vaccine shot.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
